BRCA2 and ovarian cancer: About 5–10% of all ovarian cancer cases are familial, and about 15–25% of hereditary ovarian cancer (HOC) cases are mediated by high-penetrance mutations in the BRCA1 and BRCA2 genes [4, 5].